V105: non-human primate acquisition
Ended Awarded Last action
- Contract number
- 75N98025F00003
- Awardee
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $123,000
Award facts
- Contract value 100% obligated
- $123,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 112990 All Other Animal Production
- PSC
- 8820 Live Animals, Not Raised For Food
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $123,000 firm fixed-price delivery order to The University of Texas MD Anderson Cancer Center for non-human primate acquisition, with an ultimate completion date of September 18, 2026. This delivery order, issued on September 19, 2025, represents a child contract under a larger vehicle and will be performed at NIAID's primary location in Bethesda, Maryland. The award was not designated under any small business set-aside program, reflecting MD Anderson's broad competitive capabilities as a premier academic research institution.
MD Anderson Cancer Center, a state-controlled institution of higher learning, regularly executes complex federal research contracts for NIAID and other federal agencies. The non-human primate acquisition supports NIAID's mission in infectious disease and immunological research, where primate models are essential for preclinical studies, vaccine development, and investigational therapeutic testing. As a U.S. Government Entity with extensive experience in federal contracting, MD Anderson brings specialized expertise in securing and managing scientific research projects across multiple federal agencies, positioning it well to deliver the required animals and associated services within the fixed-price contract structure.
Quick answers
Who was awarded contract 75N98025F00003?
75N98025F00003 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 19, 2025.
How much is contract 75N98025F00003 worth?
The government has obligated $123,000 on 75N98025F00003.
Which agency awarded contract 75N98025F00003?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98025F00003, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N98025F00003 an order under another contract?
Yes. 75N98025F00003 is a delivery order under 75N98021D00018, an indefinite delivery contract.
Was contract 75N98025F00003 competed?
The extent of competition for 75N98025F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award